|
HIV Prevention Counseling for Men Who Have Sex with Men Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about HIV Prevention Counseling for Men Who Have Sex with Men conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. HIV Prevention Counseling for Men Who Have Sex with Men Clinical research trials and HIV Prevention Counseling for Men Who Have Sex with Men health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like HIV Prevention Counseling for Men Who Have Sex with Men. HIV Prevention Counseling for Men Who Have Sex with Men Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a HIV Prevention Counseling for Men Who Have Sex with Men clinical trial. Subjects frequently get the best healthcare possible for their HIV Prevention Counseling for Men Who Have Sex with Men condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > HIV Prevention Counseling for Men Who Have Sex with Men  HIV Prevention Counseling for Men Who Have Sex with Men
HIV Prevention Counseling for Men Who Have Sex with Men
For Condition: HIV Infections,HIV Seronegativity
Status: No longer recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: The purpose of this study is to see if a behavioral intervention, a special kind of counseling, can reduce the risk of HIV infection in men who have sex with men. The behavioral intervention will be compared to the standard risk reduction counseling that is given before and after getting an HIV test. In standard pre- and post-test counseling, everyone is told the same things about how to prevent HIV. The behavioral intervention used in this study is designed to help each individual prevent HIV according to his specific problems and needs.
Details: The intervention being evaluated in this trial is based on the extensive literature on behavioral approaches to risk reduction in MSM. These reviews recommend an intervention that, unlike the current standard HIV pre-test and post-test risk-reduction counseling, is tailored to an individual's unique problems and needs, lifestyle, and situations that contribute to high-risk behavior. Furthermore, there is a need for HIV-prevention intervention trials using biological endpoints (e.g., HIV seroconversion) in addition to behavioral change indices. Participants are randomly assigned to receive either the behavioral intervention or the control risk-reduction counseling. The same counseling staff provides the two types of treatment. The behavioral intervention consists of 10 counseling sessions within a 4-month period followed by quarterly maintenance sessions for the remainder of the 3-year follow-up. The intervention is conducted on a one-to-one basis and targets condom use, change in sexual practices associated with HIV risk, and change in sexual practices in the context of alcohol and drug use. Participants in the control group receive pre- and post-test counseling at enrollment, then semiannually through Month 36. Beginning at Month 6, all participants complete routine semiannual visits. At each visit, Risk Assessment and phlebotomy for specimen collection for HIV antibody tests are administered. As is routine in most public counseling and testing venues, participants in the control condition do not see the same counselor consistently.
Eligibility:
Study Type: Interventional, Prevention, Parallel Assignment
Minimum Age/Maximum Age: 18 Years/
Genders: Male
Protocol Entry Criteria: Inclusion Criteria Participants may be eligible for this study if they: - Are an HIV-negative man who has had anal sex with another man in the 12 months prior to study entry. - Are able to attend all scheduled study visits. - Are able to provide information for locator purposes (address, phone number, etc.). - Are at least 18 years old. Exclusion Criteria Participants will not be eligible for this study if they: - Have been in a monogamous relationship for 2 years or more with an HIV-negative man. (Monogamous is defined as a relationship in which the members of the couple engage in sexual activities with only each other.) - Have an obvious mental disorder or any another condition that would prevent them from completing the study. - Are currently enrolled in any Phase III HIV vaccine trial, including the AIDSVAX Phase III trial sponsored by VaxGen, Inc. - Are currently enrolled in HIVNET Protocol 014. - Were enrolled in the HIVNET 015 Pilot Study.
Total Enrollment: 4350
Location and Contact Information:
Overall Study Official:
ChesneyM, Study Chair,
San Francisco Dept of Hlth / AIDS Office
San Francisco, California, 94102
United States
Fenway Community Health Ctr
Boston, Massachusetts, 02115
United States
Univ of Washington
Seattle, Washington, 98104
United States
Denver Dept of Public Health / HIVNET
Denver, Colorado, 80204
United States
New York Blood Ctr
Bronx, New York, 10456
United States
Howard Brown Health Ctr
Chicago, Illinois, 60613
United States
Additional Information:
Study ID Numbers: HIVNET 015;
Study Start Date:
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000931
Other Hiv Seronegativity Studies:
1. Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
2. Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
3. A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules
4. A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults
5. A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59
Related Studies:
Other HIV Seronegativity Clinical Trials
Other California Clinical Trials
Other San Francisco Clinical Trials
HIV Prevention Counseling for Men Who Have Sex with Men
|
|
|
|
|
|
|
|
